A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

Published:2004-01 Issue:1 Volume:39 Page:188-196
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Promrat Kittichai,Lutchman Glen,Uwaifo Gabriel I.,Freedman Renee J.,Soza Alejandro,Heller Theo,Doo Edward,Ghany Marc,Premkumar Ahalya,Park Yoon,Liang T. Jake,Yanovski Jack A.,Kleiner David E.,Hoofnagle Jay H.

Publisher

Wiley

Subject

Hepatology

Reference35 articles.

1. Nonalcoholic steatohepatitis: An expanded clinical entity

2. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

3. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

4. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years

Cited by 635 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study;Metabolites;2024-06-30

2. Fatty Liver Disease;MacSween's Pathology of the Liver;2024

3. Association between hypoglycemic agent use and the risk of occurrence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus;PLOS ONE;2023-11-22

4. Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead;Acta Pharmaceutica Sinica B;2023-11

5. Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis;Cytokine;2023-10